<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kumar S</submitter><funding>NIGMS NIH HHS</funding><pagination>11412</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4848510</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7</volume><pubmed_abstract>Disordered proteins, such as those central to Alzheimer's and Parkinson's, are particularly intractable for structure-targeted therapeutic design. Here we demonstrate the capacity of a synthetic foldamer to capture structure in a disease relevant peptide. Oligoquinoline amides have a defined fold with a solvent-excluded core that is independent of its outwardly projected, derivatizable moieties. Islet amyloid polypeptide (IAPP) is a peptide central to β-cell pathology in type II diabetes. A tetraquinoline is presented that stabilizes a pre-amyloid, α-helical conformation of IAPP. This charged, dianionic compound is readily soluble in aqueous buffer, yet crosses biological membranes without cellular assistance: an unexpected capability that is a consequence of its ability to reversibly fold. The tetraquinoline docks specifically with intracellular IAPP and rescues β-cells from toxicity. Taken together, our work here supports the thesis that stabilizing non-toxic conformers of a plastic protein is a viable strategy for cytotoxic rescue addressable using oligoquinoline amides.</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Foldamer-mediated manipulation of a pre-amyloid toxin.</pubmed_title><pmcid>PMC4848510</pmcid><funding_grant_id>R01 GM094693</funding_grant_id><funding_grant_id>R01 GM102815</funding_grant_id><pubmed_authors>Schlamadinger DE</pubmed_authors><pubmed_authors>Miranker AD</pubmed_authors><pubmed_authors>Birol M</pubmed_authors><pubmed_authors>Wojcik SP</pubmed_authors><pubmed_authors>Kumar S</pubmed_authors><pubmed_authors>Rhoades E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Foldamer-mediated manipulation of a pre-amyloid toxin.</name><description>Disordered proteins, such as those central to Alzheimer's and Parkinson's, are particularly intractable for structure-targeted therapeutic design. Here we demonstrate the capacity of a synthetic foldamer to capture structure in a disease relevant peptide. Oligoquinoline amides have a defined fold with a solvent-excluded core that is independent of its outwardly projected, derivatizable moieties. Islet amyloid polypeptide (IAPP) is a peptide central to β-cell pathology in type II diabetes. A tetraquinoline is presented that stabilizes a pre-amyloid, α-helical conformation of IAPP. This charged, dianionic compound is readily soluble in aqueous buffer, yet crosses biological membranes without cellular assistance: an unexpected capability that is a consequence of its ability to reversibly fold. The tetraquinoline docks specifically with intracellular IAPP and rescues β-cells from toxicity. Taken together, our work here supports the thesis that stabilizing non-toxic conformers of a plastic protein is a viable strategy for cytotoxic rescue addressable using oligoquinoline amides.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Apr</publication><modification>2024-11-13T17:00:02.676Z</modification><creation>2019-03-27T02:12:36Z</creation></dates><accession>S-EPMC4848510</accession><cross_references><pubmed>27108700</pubmed><doi>10.1038/ncomms11412</doi></cross_references></HashMap>